Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease
Authors:
- Nicholas PlotnikoffNPNicholas Plotnikoff
- William Guy BradleyWBWilliam Guy Bradley
- Darlene GoodfellowDGDarlene Goodfellow
- 6 November 1994
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 16 (11) , 911-917
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complexAIDS, 1991
- Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.Journal of Experimental Medicine, 1991
- The Effect of Anti-Neoplastic Drugs on Murine Acquired Immunodeficiency SyndromeScience, 1991
- Zidovudine (azido dideoxythymidine) inhibits characteristic early alterations of lymphoid cell populations in retrovirus-induced murine AIDS.The Journal of Immunology, 1990
- Friend leukemia complex infection of mice as an experimental model for AIDS studiesVeterinary Immunology and Immunopathology, 1989
- Neuropeptides: Conductors of the immune orchestraLife Sciences, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Immunologic Properties of Methionine‐Enkephalin, and Therapeutic Implications in AIDS, ARC, and CancerAnnals of the New York Academy of Sciences, 1987
- Retrovirus-Induced Acquired Immunodeficiencies1985
- Suggestive Evidence for Receptors for Morphine and Methionine-Enkephalin on Normal Human Blood T LymphocytesThe Journal of Immunology, 1979